Jessica Demarchis, in Albrightsville, PA - Social Worker

Jessica Demarchis, is a Social Worker - Clinical based in Albrightsville, Pennsylvania. Jessica Demarchis is licensed to practice in * (Not Available) (license number ) and her current practice location is 5 Hunter Ln, Albrightsville, Pennsylvania. She can be reached at her office (for appointments etc.) via phone at (570) 269-7172.

NPI number for Jessica Demarchis is 1114327228 and her current mailing address is 5 Hunter Ln, Albrightsville, Pennsylvania. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1114327228.

Contact Information

	Jessica Demarchis,
	5 Hunter Ln, Albrightsville, PA 18210-3816
	(570) 269-7172
	Not Available

Healthcare Provider's Profile

Full Name	Jessica Demarchis
Gender	Female
Speciality	Social Worker - Clinical
Location	5 Hunter Ln, Albrightsville, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1114327228
Provider Enumeration Date: 08/26/2014
Last Update Date: 08/26/2014

Medical Identifiers

Medical identifiers for Jessica Demarchis such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1114327228	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jessica Demarchis is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jessica Demarchis, 5 Hunter Ln, Albrightsville, PA 18210-3816 Ph: (570) 269-7172	Jessica Demarchis, 5 Hunter Ln, Albrightsville, PA 18210-3816 Ph: (570) 269-7172

News Archive

GSK receives FDA approval for raxibacumab to treat inhalational anthrax

The U.S. Food and Drug Administration today approved raxibacumab injection to treat inhalational anthrax, a form of the infectious disease caused by breathing in the spores of the bacterium Bacillus anthracis. Raxibacumab also is approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.

Immune system plays paradoxical role in breast cancer metastasis

The immune system plays a paradoxical role in the spread of breast cancer. Some immune cells contribute to metastasis, while other cells can be activated to strengthen the effect of chemotherapy.

Walnuts may prevent breast cancer

A new study has found that eating a handful of walnuts on a regular basis may reduce women's risk of developing breast cancer. Researchers from the Marshall University observed in mice that consuming 2 ounces of walnuts each day reduced the growth of breast cancer tumors.

Modified skin biopsy could provide faster and better diagnosis of inherited, fatal nerve disease

Johns Hopkins physicians report success in a small study of a modified skin biopsy that hastens the earlier diagnosis of an inherited and progressively fatal nerve disease and seems to offer a clearer view of the disorder's severity and progression.

Hertfordshire to train new mental health workforce

The University's School of Social Community & Health Studies has won a three year contract worth one million pounds a year with the East of England Strategic Health Authority to implement training for a major government policy in mental health entitled Improving Access to Psychological Therapies (IAPT).

Jessica Demarchis, - Clinical Social Worker in Albrightsville, PA